Rankings
▼
Calendar
BLFS Q4 2024 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena
BLFS
BioLife Solutions, Inc.
$921M
Q4 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
-$3M
-119.7% YoY
Gross Profit
$8M
-241.6% margin
Operating Income
$1M
-40.5% margin
Net Income
$12M
-363.9% margin
EPS (Diluted)
$0.26
QoQ Revenue Growth
-111.2%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$583,000
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$399M
Total Liabilities
$51M
Stockholders' Equity
$349M
Cash & Equivalents
$95M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
-$3M
$17M
-119.7%
Gross Profit
$8M
$9M
-8.7%
Operating Income
$1M
-$7M
+118.6%
Net Income
$12M
-$13M
+193.1%
Revenue Segments
Product
$28M
100%
← FY 2024
All Quarters
Q1 2025 →